Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bevin Valdez Lopez"'
Autor:
Bevin Valdez Lopez, Edward A. Graviss, Duc T. Nguyen, Paul A. Christensen, Jimmy Gollihar, James M. Musser, John Rogers, Picheng Zhao, Randall J. Olsen, Eric Salazar, Todd N. Eagar, Xin Yi, Ahmed Shehabeldin, Christopher Leveque, Brian Castillo, Jian Chen, David Joseph, David W. Bernard
Publikováno v:
The American Journal of Pathology
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and proven treatments are limited. Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 is among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a931ccbe5ef5c09212c0fd8f8b41291
https://doi.org/10.1016/j.ajpath.2020.08.001
https://doi.org/10.1016/j.ajpath.2020.08.001
Autor:
Katherine K. Perez, Randall J. Olsen, Jian Chen, Eric Salazar, John Rogers, S. Wesley Long, Jimmy Gollihar, Matthew Ojeda Saavedra, Bevin Valdez Lopez, Brian Castillo, Ahmed Shehabeldin, Andre C. Maranhao, David Joseph, Todd N. Eagar, Cheryl Chavez-East, Paul A. Christensen, David W. Bernard, Christina Talley, Christopher Leveque, Karen D. Thomas, Monisha Dey, Concepcion C. Cantu, Madiha Ashraf, Faisal Masud, Katharine G. Dlouhy, Taryn A Eubank, Prasanti Yerramilli, Curt Hampton, Sishir Subedi, Jason J. Lavinder, Layne Pruitt, James M. Musser, Gregory C. Ippolito, Mary R. Schwartz, Guy Williams
Publikováno v:
The American Journal of Pathology
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and no proven treatments are available. Convalescent plasma therapy has been used with varying degrees of success to treat severe mic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52598a098fdefedc433f2f7a88c71424
https://doi.org/10.1016/j.ajpath.2020.05.014
https://doi.org/10.1016/j.ajpath.2020.05.014
Autor:
David Joseph, David W. Bernard, Jimmy Gollihar, Bevin Valdez Lopez, John Rogers, James M. Musser, Duc T. Nguyen, Ahmed Shehabeldin, Randall J. Olsen, Paul A. Christensen, Faisal Masud, Xin Yi, Christopher Leveque, Eric Salazar, Picheng Zhao, Jian Chen, Edward A. Graviss, Todd N. Eagar, Brian Castillo
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 remains a global threat with few proven efficacious treatments. Transfusion of convalescent plasma collected from donors who have recovered from COVID-19 di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7eb86e3be4cad95a0aaa6025c5db23bc
https://doi.org/10.1101/2020.10.02.20206029
https://doi.org/10.1101/2020.10.02.20206029
Autor:
Hampton C, Chavez-East C, Todd N. Eagar, Prasanti Yerramilli, John Rogers, Taryn A Eubank, Gregory C. Ippolito, Layne Pruitt, Dey M, James M. Musser, Concepcion C. Cantu, David Joseph, Mary R. Schwartz, Andre C. Maranhao, Randall J. Olsen, Paul A. Christensen, David W. Bernard, Christopher Leveque, Brian Castillo, Eric Salazar, Faisal Masud, Scott Wesley Long, Talley C, Matthew Ojeda Saavedra, Williams G, Ahmed Shehabeldin, Madiha Ashraf, Karen D. Thomas, Bevin Valdez Lopez, Jian Chen, Katharine G. Dlouhy, Sishir Subedi, Jason J. Lavinder, Katherine K. Perez, Jimmy Gollihar
Publikováno v:
medRxiv
BackgroundCOVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread globally, and no proven treatments are available. Convalescent plasma therapy has been used with varying degrees of success to treat severe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c9a8a113aea60446274e998c0f15dd
https://pubmed.ncbi.nlm.nih.gov/32473109
https://pubmed.ncbi.nlm.nih.gov/32473109